Published in Science on December 05, 2008
Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A (2010) 11.21
FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol (2010) 8.73
Fetal and adult hematopoietic stem cells give rise to distinct T cell lineages in humans. Science (2010) 4.22
Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit. Blood (2009) 3.05
Innate and adaptive immune responses in asthma. Nat Med (2012) 2.73
Preterm labor: one syndrome, many causes. Science (2014) 2.61
IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol (2011) 2.36
The immune system in pregnancy: a unique complexity. Am J Reprod Immunol (2010) 2.33
Challenges in infant immunity: implications for responses to infection and vaccines. Nat Immunol (2011) 2.17
How tolerogenic dendritic cells induce regulatory T cells. Adv Immunol (2010) 2.11
Generation and large-scale expansion of human inducible regulatory T cells that suppress graft-versus-host disease. Am J Transplant (2011) 1.96
Naturally acquired tolerance and sensitization to minor histocompatibility antigens in healthy family members. Blood (2009) 1.94
Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies. Proc Natl Acad Sci U S A (2009) 1.78
Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy. Biol Blood Marrow Transplant (2012) 1.72
HLA mismatch direction in cord blood transplantation: impact on outcome and implications for cord blood unit selection. Blood (2011) 1.71
Microchimerism is strongly correlated with tolerance to noninherited maternal antigens in mice. Blood (2009) 1.63
Pretransplant immune regulation predicts allograft outcome: bidirectional regulation correlates with excellent renal transplant function in living-related donor-recipient pairs. Transplantation (2012) 1.63
Microbial contact during pregnancy, intestinal colonization and human disease. Nat Rev Gastroenterol Hepatol (2012) 1.62
Patterns of early gut colonization shape future immune responses of the host. PLoS One (2012) 1.56
Fetomaternal immune cross-talk and its consequences for maternal and offspring's health. Nat Med (2013) 1.54
Cesarean versus vaginal delivery: long-term infant outcomes and the hygiene hypothesis. Clin Perinatol (2011) 1.52
The otherness of self: microchimerism in health and disease. Trends Immunol (2012) 1.46
Regulatory T cell frequencies are increased in preterm infants with clinical early-onset sepsis. Clin Exp Immunol (2016) 1.43
Human cytomegalovirus elicits fetal gammadelta T cell responses in utero. J Exp Med (2010) 1.39
Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates. Nat Rev Immunol (2013) 1.39
Viral infection of the placenta leads to fetal inflammation and sensitization to bacterial products predisposing to preterm labor. J Immunol (2010) 1.39
Ontogeny of early life immunity. Trends Immunol (2014) 1.35
Role of the PD-1 pathway in the immune response. Am J Transplant (2012) 1.35
Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma. Nat Med (2012) 1.33
Pathogens and the placental fortress. Curr Opin Microbiol (2011) 1.33
The biodiversity hypothesis and allergic disease: world allergy organization position statement. World Allergy Organ J (2013) 1.32
Overview of the immune response. J Allergy Clin Immunol (2010) 1.32
Indirect evidence that maternal microchimerism in cord blood mediates a graft-versus-leukemia effect in cord blood transplantation. Proc Natl Acad Sci U S A (2012) 1.31
Regulatory T cells in many flavors control asthma. Mucosal Immunol (2010) 1.28
Pregnancy induces a fetal antigen-specific maternal T regulatory cell response that contributes to tolerance. Proc Natl Acad Sci U S A (2010) 1.26
Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function. J Transl Med (2009) 1.26
Immunity, thyroid function and pregnancy: molecular mechanisms. Nat Rev Endocrinol (2010) 1.25
Maternal T cells limit engraftment after in utero hematopoietic cell transplantation in mice. J Clin Invest (2011) 1.25
Clinical perspectives for regulatory T cells in transplantation tolerance. Semin Immunol (2011) 1.23
The impact of differential antiviral immunity in children and adults. Nat Rev Immunol (2012) 1.21
Tissue barriers of the human placenta to infection with Toxoplasma gondii. Infect Immun (2011) 1.17
Maternal alloantibodies induce a postnatal immune response that limits engraftment following in utero hematopoietic cell transplantation in mice. J Clin Invest (2009) 1.16
Nutritionally mediated programming of the developing immune system. Adv Nutr (2011) 1.16
An overview of the progress on double umbilical cord blood transplantation. Haematologica (2011) 1.15
The link between the PDL1 costimulatory pathway and Th17 in fetomaternal tolerance. J Immunol (2011) 1.10
A lesson in tolerance--maternal instruction to fetal cells. N Engl J Med (2009) 1.09
Tolerance to noninherited maternal antigens in mice and humans. Curr Opin Organ Transplant (2009) 1.09
Intra-amniotic IL-1β induces fetal inflammation in rhesus monkeys and alters the regulatory T cell/IL-17 balance. J Immunol (2013) 1.08
Effect of parity on fetal and maternal microchimerism: interaction of grafts within a host? Blood (2010) 1.08
Expression of the autoimmune susceptibility gene FcRL3 on human regulatory T cells is associated with dysfunction and high levels of programmed cell death-1. J Immunol (2010) 1.08
Cross-Generational Reproductive Fitness Enforced by Microchimeric Maternal Cells. Cell (2015) 1.07
CD8α+ plasmacytoid precursor DCs induce antigen-specific regulatory T cells that enhance HSC engraftment in vivo. Blood (2010) 1.07
Early-life compartmentalization of human T cell differentiation and regulatory function in mucosal and lymphoid tissues. Nat Med (2015) 1.07
Age predicts cytokine kinetics and innate immune cell activation following intranasal delivery of IFNγ and GM-CSF in a mouse model of RSV infection. Cytokine (2017) 1.06
Immune responses in neonates. Expert Rev Clin Immunol (2014) 1.06
Mother and child T cell receptor repertoires: deep profiling study. Front Immunol (2013) 1.06
Immunity to HIV in Early Life. Front Immunol (2014) 1.05
Fetal regulatory T cells and peripheral immune tolerance in utero: implications for development and disease. Am J Reprod Immunol (2013) 1.04
Pretransplant immune-regulation predicts allograft tolerance. Am J Transplant (2011) 1.04
Immunology of pediatric HIV infection. Immunol Rev (2013) 1.02
Genetics of SCID. Ital J Pediatr (2010) 1.02
Antibody-dependent transplacental transfer of malaria blood-stage antigen using a human ex vivo placental perfusion model. PLoS One (2009) 1.01
Progesterone promotes differentiation of human cord blood fetal T cells into T regulatory cells but suppresses their differentiation into Th17 cells. J Immunol (2011) 1.00
Cutting edge: inhaled antigen upregulates retinaldehyde dehydrogenase in lung CD103+ but not plasmacytoid dendritic cells to induce Foxp3 de novo in CD4+ T cells and promote airway tolerance. J Immunol (2013) 1.00
Acquiring and maintaining a normal oral microbiome: current perspective. Front Cell Infect Microbiol (2014) 1.00
Trained immunity in newborn infants of HBV-infected mothers. Nat Commun (2015) 0.98
T cell receptor signalling in the control of regulatory T cell differentiation and function. Nat Rev Immunol (2016) 0.97
Maternal bereavement and childhood asthma-analyses in two large samples of Swedish children. PLoS One (2011) 0.97
Early-life exposure to combustion-derived particulate matter causes pulmonary immunosuppression. Mucosal Immunol (2013) 0.96
Dynamic changes in fetal microchimerism in maternal peripheral blood mononuclear cells, CD4+ and CD8+ cells in normal pregnancy. Placenta (2010) 0.96
Maternal influences on fetal microbial colonization and immune development. Pediatr Res (2014) 0.96
The role of transplacental microtransfusions of maternal lymphocytes in in utero HIV transmission. J Acquir Immune Defic Syndr (2010) 0.96
Regulatory T cell memory. Nat Rev Immunol (2015) 0.96
What infants and breasts can teach us about natural protection from HIV infection. J Infect Dis (2010) 0.95
Soothing signals: transplacental transmission of resistance to asthma and allergy. J Exp Med (2009) 0.95
Pregnancy, microchimerism, and the maternal grandmother. PLoS One (2011) 0.94
Thymic changes after chorioamnionitis induced by intraamniotic lipopolysaccharide in fetal sheep. Am J Obstet Gynecol (2010) 0.94
Differentiation and functional regulation of human fetal NK cells. J Clin Invest (2013) 0.94
Distinct functional programming of human fetal and adult monocytes. Blood (2014) 0.93
The immunologic basis for severe neonatal herpes disease and potential strategies for therapeutic intervention. Clin Dev Immunol (2013) 0.93
Plasmodium falciparum infection of the placenta impacts on the T helper type 1 (Th1)/Th2 balance of neonatal T cells through CD4(+)CD25(+) forkhead box P3(+) regulatory T cells and interleukin-10. Clin Exp Immunol (2009) 0.93
Acquisition and maturation of oral microbiome throughout childhood: An update. Dent Res J (Isfahan) (2014) 0.93
Umbilical cord blood transplantation supported by third-party donor cells: rationale, results, and applications. Biol Blood Marrow Transplant (2012) 0.93
An optimized multi-parameter flow cytometry protocol for human T regulatory cell analysis on fresh and viably frozen cells, correlation with epigenetic analysis, and comparison of cord and adult blood. J Immunol Methods (2012) 0.92
Infected dendritic cells facilitate systemic dissemination and transplacental passage of the obligate intracellular parasite Neospora caninum in mice. PLoS One (2012) 0.91
Microchimerism: tolerance vs. sensitization. Curr Opin Organ Transplant (2011) 0.91
Immunological implications of pregnancy-induced microchimerism. Nat Rev Immunol (2017) 0.91
Pathogenesis of hepatitis C during pregnancy and childhood. Viruses (2012) 0.90
Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance. Am J Obstet Gynecol (2015) 0.89
Haploidentical transplantation for leukemia. Curr Oncol Rep (2010) 0.89
Effect of chorioamnionitis on regulatory T cells in moderate/late preterm neonates. Hum Immunol (2014) 0.89
Immune mechanisms at the maternal-fetal interface: perspectives and challenges. Nat Immunol (2015) 0.89
Stem cell microchimerism and tolerance to non-inherited maternal antigens. Chimerism (2016) 0.89
Placental Hofbauer cells limit HIV-1 replication and potentially offset mother to child transmission (MTCT) by induction of immunoregulatory cytokines. Retrovirology (2012) 0.89
Tolerogenic effect of non-inherited maternal antigens in hematopoietic stem cell transplantation. Front Immunol (2012) 0.88
Regulatory T cells and parasites. J Biomed Biotechnol (2011) 0.88
The role of myeloid-derived suppressor cells in immune ontogeny. Front Immunol (2014) 0.88
At the crossroads between tolerance and aggression: Revisiting the "layered immune system" hypothesis. Chimerism (2011) 0.88
Phenotypic characterization of leukocytes in prenatal human dermis. J Invest Dermatol (2012) 0.88
Control of regulatory T cell development by the transcription factor Foxp3. Science (2003) 40.32
Actively acquired tolerance of foreign cells. Nature (1953) 19.82
How regulatory T cells work. Nat Rev Immunol (2008) 11.66
Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol (2004) 5.24
Organogenesis of lymphoid tissues. Nat Rev Immunol (2003) 4.53
The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors. N Engl J Med (1998) 3.86
THE SELECTIVITY OF THE HUMAN PLACENTA IN THE TRANSFER OF PLASMA PROTEINS FROM MOTHER TO FETUS. J Clin Invest (1964) 3.33
Induction of B cell unresponsiveness to noninherited maternal HLA antigens during fetal life. Science (1988) 2.28
Microchimerism: an investigative frontier in autoimmunity and transplantation. JAMA (2004) 1.95
Mature CD8(+) T lymphocyte response to viral infection during fetal life. J Clin Invest (2003) 1.85
CD25+CD4+ T cells in human cord blood: an immunoregulatory subset with naive phenotype and specific expression of forkhead box p3 (Foxp3) gene. Exp Hematol (2004) 1.84
Regulation of T cell responses in the developing human fetus. J Immunol (2006) 1.78
Tgf-Beta signaling in development. Sci STKE (2007) 1.70
Maternal microchimerism in healthy adults in lymphocytes, monocyte/macrophages and NK cells. Lab Invest (2006) 1.61
ONTOGENY OF THE IMMUNE RESPONSE. Science (1964) 1.54
Transplacentally acquired maternal T lymphocytes in severe combined immunodeficiency: a study of 121 patients. Blood (2001) 1.50
Enhanced ascertainment of microchimerism with real-time quantitative polymerase chain reaction amplification of insertion-deletion polymorphisms. Transfusion (2006) 1.50
Early human T cell development: analysis of the human thymus at the time of initial entry of hematopoietic stem cells into the fetal thymic microenvironment. J Exp Med (1995) 1.38
Antigen-specific immune responses to influenza vaccine in utero. J Clin Invest (2007) 1.36
Development of cell-mediated lympholysis in human foetal blood lymphocytes. Clin Exp Immunol (1980) 1.31
Lymphoid tissue architecture. II. Ontogeny of peripheral T and B cells in mice: evidence against Peyer's patches as the site of generation of B cells. J Immunol (1974) 1.27
Defining critical windows in the development of the human immune system. Hum Exp Toxicol (2002) 1.25
Cell-mediated lympholysis by fetal and neonatal lymphocytes in sheep and man. Cell Immunol (1980) 1.22
Maternal microchimerism in human fetal tissues. Am J Obstet Gynecol (2008) 1.20
Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A (2008) 16.54
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature (2009) 13.99
Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS (2003) 11.66
Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis (2008) 6.03
Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J Exp Med (2008) 5.94
Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med (2004) 5.78
Public health. A sound rationale needed for phase III HIV-1 vaccine trials. Science (2004) 5.31
Seroconversion following nonoccupational postexposure prophylaxis against HIV. Clin Infect Dis (2005) 4.27
Pegylated Interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integration. J Infect Dis (2012) 4.24
Fetal and adult hematopoietic stem cells give rise to distinct T cell lineages in humans. Science (2010) 4.22
Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci Transl Med (2010) 4.07
Time trends in primary HIV-1 drug resistance among recently infected persons. JAMA (2002) 4.02
Ten-year incidence of Chagas cardiomyopathy among asymptomatic Trypanosoma cruzi-seropositive former blood donors. Circulation (2013) 3.84
Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J Infect Dis (2002) 3.83
Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells. J Biol Chem (2009) 3.71
Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood (2010) 3.58
Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J Virol (2004) 3.58
Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc Natl Acad Sci U S A (2011) 3.53
Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathog (2009) 3.35
Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study. Hepatology (2013) 3.35
CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. Blood (2010) 3.32
Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases. Ann Intern Med (2014) 3.24
Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS (2002) 3.22
A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response. J Infect Dis (2011) 3.10
Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses. AIDS (2006) 2.98
Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy. J Virol (2008) 2.90
Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J Exp Med (2010) 2.89
Education of human natural killer cells by activating killer cell immunoglobulin-like receptors. Blood (2009) 2.88
Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection. J Infect Dis (2009) 2.82
Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trial. J Infect Dis (2013) 2.82
Prevalence of CXCR4 tropism among antiretroviral-treated HIV-1-infected patients with detectable viremia. J Infect Dis (2006) 2.74
The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion (2009) 2.56
Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci Transl Med (2013) 2.47
Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient. PLoS Pathog (2013) 2.44
Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4. Blood (2009) 2.43
Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation. AIDS (2010) 2.43
Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression. Proc Natl Acad Sci U S A (2008) 2.38
Growth hormone enhances thymic function in HIV-1-infected adults. J Clin Invest (2008) 2.35
Biospecimen repositories: are blood donors willing to participate? Transfusion (2010) 2.33
Subpopulations of long-lived and short-lived T cells in advanced HIV-1 infection. J Clin Invest (2003) 2.33
Optimization of methods to assess human mucosal T-cell responses to HIV infection. J Immunol Methods (2003) 2.32
Modeling sequence evolution in acute HIV-1 infection. J Theor Biol (2009) 2.32
The consequences of temporary deferral on future whole blood donation. Transfusion (2007) 2.31
Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells. J Immunol Methods (2003) 2.28
Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus. Transfusion (2008) 2.27
Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size. J Infect Dis (2013) 2.23
Development of a new less-sensitive enzyme immunoassay for detection of early HIV-1 infection. J Acquir Immune Defic Syndr (2003) 2.21
Tregs control the development of symptomatic West Nile virus infection in humans and mice. J Clin Invest (2009) 2.18
Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation. J Infect Dis (2013) 2.17
Human CD4+ regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells. J Immunol Methods (2006) 2.14
The detection of acute HIV infection. J Infect Dis (2010) 2.14
Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers. PLoS Pathog (2013) 2.06
NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood (2013) 2.04
Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B. J Clin Invest (2013) 2.04
Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial. Ann Intern Med (2003) 2.02
The impact of male-to-male sexual experience on risk profiles of blood donors. Transfusion (2005) 2.02
Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion. Transfusion (2009) 2.00
Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion (2003) 2.00
Transcriptional profiling in pathogenic and non-pathogenic SIV infections reveals significant distinctions in kinetics and tissue compartmentalization. PLoS Pathog (2009) 1.99
Multiparameter evaluation of human thymic function: interpretations and caveats. Clin Immunol (2005) 1.97
The whole is greater than the sum of its parts: hemostatic profiles of whole blood variants. J Trauma Acute Care Surg (2014) 1.88
The cost-effectiveness of screening the U.S. blood supply for West Nile virus. Ann Intern Med (2005) 1.88
Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7. PLoS Pathog (2012) 1.88
Cytotrophoblast induction of arterial apoptosis and lymphangiogenesis in an in vivo model of human placentation. J Clin Invest (2006) 1.88
Cutting Edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation. J Immunol (2007) 1.87
Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells. J Infect Dis (2012) 1.86
Quantitative estimate of the risks and benefits of possible alternative blood donor deferral strategies for men who have had sex with men. Transfusion (2009) 1.85
Donation archives and prospective donor-recipient repositories: indispensable tools for monitoring blood safety. Transfusion (2007) 1.85
Prevalence, incidence, and residual risk of human immunodeficiency virus among community and replacement first-time blood donors in São Paulo, Brazil. Transfusion (2005) 1.84
Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection. AIDS Res Hum Retroviruses (2006) 1.83
Cytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV disease. PLoS One (2010) 1.83
Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Ann Intern Med (2013) 1.82
High specific infectivity of plasma virus from the pre-ramp-up and ramp-up stages of acute simian immunodeficiency virus infection. J Virol (2009) 1.82
Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity. Blood (2012) 1.81
Direct measurement of T-cell receptor repertoire diversity with AmpliCot. Nat Methods (2006) 1.80
Prevalence of HIV-1 in blood donations following implementation of a structured blood safety policy in South Africa. JAMA (2006) 1.78
Regulation of T cell responses in the developing human fetus. J Immunol (2006) 1.78
Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia. AIDS (2004) 1.75
Selective loss of innate CD4(+) V alpha 24 natural killer T cells in human immunodeficiency virus infection. J Virol (2002) 1.74